Strategies for Organic Drug Synthesis and Design
Regular price
€203.30
14 days return policy
Shipping & Delivery
A01=Daniel Lednicer
Author_Daniel Lednicer
blueprint
Category=MKG
Category=TDCW
chemistry
companies
developments
drug
drug synthesis
edition
edition focuses
eq_bestseller
eq_isMigrated=1
eq_nobargain
eq_non-fiction
eq_tech-engineering
examples
field
latest
major pharmaceutical
multivolume work
new
organic chemistry
readers
synthesis
testedandproven strategies
Product details
- ISBN 9780470190395
- Weight: 1089g
- Dimensions: 163 x 236mm
- Publication Date: 14 Nov 2008
- Publisher: John Wiley & Sons Inc
- Publication City/Country: US
- Product Form: Hardback
Secure
checkout
Fast Shipping
Easy returns
This book examines and evaluates the strategies utilized to design and synthesize pharmaceutically active agents. Significant updates over the last 10 years since the publication of the 1st edition include synthesis of enantiomerically pure isomers, novel chemical methodologies, and new pharmaceutical agents targeted at novel biological endpoints. Written by an experienced successful author, this book meets the needs of a growing community of researchers in pharmaceutical R &D, as well as medical professionals, by providing a useful guide for designing and synthesizing pharmaceutical agents. Additionally, it is a useful text for medicinal chemistry students.
Daniel Lednicer, PhD, is the acclaimed author of several books on drug synthesis and discovery. His career has been devoted to the search for new therapeutic agents. Dr. Lednicer spent two decades at the bench as a chemist at the Upjohn Company. He has also served as director of chemical research at Mead Johnson, director of pharmaceutical sciences at Adria Laboratories, and pharmaceutical manager at Analytical Biochemistry Laboratories. Most recently, he was a project officer at the National Cancer Institute.
